SMAD4 and head and neck squamous cell carcinoma: Hernandez et al. developed a SMAD4 fluorescence in situ hybridization assay to measure chromosomal SMAD4 loss at the single-cell level in primary HNSCC samples and in and patient-derived xenografted (PDX) HNSCC tumors (61).